In general, for both pPCa and mCRPC cancers, CDK12 -mut tumors expressing higher MHC levels were associated with transcriptomic changes that indicate a general pattern of activation of IFN-γ-responsive and cytotoxic activity genes. The gene discussed is HLA-C; the disease is cancer.